Finnish drug delivery technology and drug development company DelSiTech Ltd announces and welcomes Dr. Marceline Akieh-Pirkanniemi, as the new Director, Head of Analytical Development. The new position took effect in the beginning of January 2020.
Marceline Akieh-Pirkanniemi has a PhD in Analytical Chemistry from Åbo Akademi University. She brings with her 12 years of analytical experience gained from her time in both academia and the private sector. She has long-term experience of working with biodegradable and non-biodegradable drug delivery/carrier systems. She has worked as an analytical specialist in other pharmaceutical companies. Her core competence includes drug substance and excipient characterization using chromatographic and spectroscopic techniques.
‘’I am enthusiastic to work with a brilliant and skilled team to provide analytical support to DelSiTech’s proprietary silica-based drug delivery platform. This silica drug delivery technology will shift the paradigm in today’s medicine, e.g. in providing stable viral vaccines and long-lasting injectables for global health challenges.’’ said Marceline.
Lasse Leino, CEO of DelSiTech expressed confidence that Marceline is ready to handle the position, saying: “The joining of Marceline corresponds with the company’s business growth strategy. The fact that Marceline has an in-depth analytical knowledge and hands on analytical capabilities will complement our growing analytical development team.”